LORATADINE: 25,422 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Route: ORAL · Manufacturer: Little Pharma, Inc. · FDA Application: 019658 · HUMAN OTC DRUG · FDA Label: Available
First Report: 1974 · Latest Report: 20250919
What Are the Most Common LORATADINE Side Effects?
All LORATADINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 7,516 | 29.6% | 17 | 73 |
| Extra dose administered | 1,556 | 6.1% | 0 | 1 |
| Somnolence | 1,391 | 5.5% | 4 | 379 |
| Off label use | 1,386 | 5.5% | 13 | 73 |
| Product use issue | 1,371 | 5.4% | 11 | 8 |
| Expired product administered | 1,095 | 4.3% | 0 | 1 |
| Product use in unapproved indication | 902 | 3.6% | 1 | 44 |
| Accidental exposure to product by child | 830 | 3.3% | 0 | 3 |
| Drug effect incomplete | 679 | 2.7% | 0 | 0 |
| Dizziness | 674 | 2.7% | 2 | 64 |
| Headache | 654 | 2.6% | 8 | 79 |
| Incorrect dose administered | 614 | 2.4% | 0 | 13 |
| Fatigue | 596 | 2.3% | 11 | 77 |
| Drug ineffective for unapproved indication | 487 | 1.9% | 0 | 14 |
| Nausea | 469 | 1.8% | 8 | 51 |
| Therapeutic response unexpected | 453 | 1.8% | 0 | 1 |
| Drug hypersensitivity | 430 | 1.7% | 7 | 33 |
| Dyspnoea | 420 | 1.7% | 3 | 81 |
| Insomnia | 413 | 1.6% | 0 | 36 |
| Urticaria | 409 | 1.6% | 0 | 56 |
Who Reports LORATADINE Side Effects? Age & Gender Data
Gender: 64.7% female, 35.3% male. Average age: 47.7 years. Most reports from: US. View detailed demographics →
Is LORATADINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 6 | 0 | 3 |
| 2001 | 5 | 0 | 1 |
| 2002 | 4 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 4 | 1 | 0 |
| 2005 | 5 | 0 | 1 |
| 2006 | 12 | 1 | 2 |
| 2007 | 7 | 1 | 0 |
| 2008 | 23 | 1 | 16 |
| 2009 | 11 | 0 | 3 |
| 2010 | 17 | 0 | 0 |
| 2011 | 28 | 1 | 5 |
| 2012 | 41 | 3 | 3 |
| 2013 | 78 | 3 | 12 |
| 2014 | 751 | 3 | 66 |
| 2015 | 1,607 | 11 | 35 |
| 2016 | 1,703 | 14 | 61 |
| 2017 | 1,575 | 21 | 51 |
| 2018 | 1,311 | 11 | 79 |
| 2019 | 1,269 | 7 | 60 |
| 2020 | 760 | 3 | 47 |
| 2021 | 854 | 17 | 75 |
| 2022 | 550 | 17 | 31 |
| 2023 | 433 | 9 | 22 |
| 2024 | 344 | 1 | 28 |
| 2025 | 205 | 1 | 14 |
What Is LORATADINE Used For?
| Indication | Reports |
|---|---|
| Hypersensitivity | 6,046 |
| Product used for unknown indication | 4,530 |
| Nasopharyngitis | 3,982 |
| Seasonal allergy | 2,587 |
| Rhinorrhoea | 1,438 |
| Sneezing | 690 |
| Multiple allergies | 571 |
| Nasal congestion | 475 |
| Viral upper respiratory tract infection | 469 |
| Lacrimation increased | 463 |
LORATADINE vs Alternatives: Which Is Safer?
Official FDA Label for LORATADINE
Official prescribing information from the FDA-approved drug label.
FDA Approved Uses (Indications)
Uses
- temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
- sneezing
- itchy, watery eyes
- runny nose
- itching of the nose or throat
- temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies
- reduces swelling of nasal passages
- temporarily relieves sinus congestion and pressure
- temporarily restores freer breathing through the nose
Dosage & Administration
Directions adults and children 6 years and over 2 teaspoonfuls (TSP) daily; do not take more than 2 teaspoonfuls (TSP) in 24 hours children 2 to under 6 years of age 1 teaspoonful (TSP) daily; do not take more than 1 teaspoonful (TSP) in 24 hours children under 2 years of age ask a doctor consumers with liver or kidney disease ask a doctor
Directions adults and children 6 years and over 2 teaspoonfuls (tsp) daily; do not take more than 2 teaspoonfuls (tsp) in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor Other information Safety sealed. Do not use if imprinted seal around cap is broken or missing Store between 20° to 25°C (68° to 77°F)
Warnings
Warnings Do not use if you have ever had allergic reaction to this product or any of it's ingredients Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children . In case of overdose, get medical help or contact a Poison Control Center right away.
Warnings Severe Allergy
Warning : Get emergency help immediately if you have hives along with any of the following symptoms: trouble swallowing dizziness or loss of consciousness swelling of tongue swelling in or around mouth trouble speaking drooling wheezing or problems breathing These symptoms may be signs of anaphylactic shock. This condition can be life threatening if not treated by a health professional immediately . Symptoms of anaphylactic shock may occur when hives first appear or up to a few hours later. Not a Substitute for Epinephrine . If your doctor has prescribed an epinephrine injector for “anaphylaxis” or severe allergy symptoms that could occur with your hives, never use this product as a substitute for the epinephrine injector. If you have been prescribed an epinephrine injector, you should carry it with you at all times. Do not use - to prevent hives from any known cause such as: foods insects stings medicines latex or rubber gloves because this product will not stop hives from occurring. Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a cause. - if you have ever had an allergic reaction to this product (loratadine) or any of its ingredients Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. hives that are an unusual color, look bruised or blistered hives that do not itch When using this product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs. Get medical help right away symptoms don’t improve after 3 days of treatment the hives have lasted more than 6 weeks If pregnant or breast-feeding , ask a health professional before use. Keep out of reach of children . In case of overdose, get medical help or contact a Poison Control Center right away.
Active Ingredient
Drug Facts Active ingredient (in each tablet)
Purpose
Loratadine USP, 10 mg………………………………….....................Antihistamine Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: ■ runny nose ■ itchy, watery eyes ■ sneezing ■ itching of the nose or throat Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients. Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using a product do not take more than directed. Taking more than directed may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Directions place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours Children under 6 years of age ask a doctor Consumers with liver or kidney disease ask a doctor Other information Phenylketonurics: contains phenylalanine (a component of aspartame) 1.52 mg per 10 mg orally disintegrating tablet. safety sealed: do not use if the individual blister unit imprinted with Loratadine Orally Disintegrating Tablets USP 10 mg is open or torn store between 20° to 25°C (68° to 77°F) use tablet immediately after opening individual blister FDA approved acceptance criteria for assay and organic impurities differs from USP test Inactive ingredients aspartame, colloidal silicon dioxide, crospovidone, magnesium stearate, maize starch, mannitol, microcrystalline cellulose, peppermint flavor, sodium stearyl fumarate Questions or comments? Advagen - 866-488-0312 Distributed by: Advagen Pharma Ltd East Windsor, NJ 08520, USA Manufactured by: Rubicon Research Ltd., Thane 421506, India. Rev. 02, 11/24
Inactive Ingredients
Inactive ingredients Grape chewable tablets aspartame, citric acid anhydrous, colloidal silicon dioxide, D&C red No. 27 aluminum lake, FD&C blue No. 2 aluminum lake, flavor, magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate, stearic aicd Bubblegum chewable tablets aspartame, carmine, citric acid, colloidal silicon dioxide, flavor, magnesium stearate, mannitol, microcrystalline cellulose, sodium starch glycolate, stearic acid